Literature DB >> 20395674

Flying with respiratory disease.

Panagiota Tzani1, Giovanna Pisi, Marina Aiello, Dario Olivieri, Alfredo Chetta.   

Abstract

Patients with respiratory diseases may be at risk during flight because at cruising altitude an important hypobaric hypoxia may occur. The only absolute contraindications to flying in these patients are pneumothorax, bronchogenic cyst and severe pulmonary hypertension. In order to evaluate the risks related to air travel in patients with respiratory diseases, an evaluation of their fitness to fly, including the hypoxia altitude simulation test, is required. The fitness to fly evaluation can identify patients requiring supplemental oxygen during flight which is provided by most airlines when prescribed by the passenger's physician. This review deals with the cardiorespiratory effects of flight, the risks associated with respiratory diseases during air travel and the procedures to follow in order to assess fitness to fly in patients with respiratory disorders. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20395674     DOI: 10.1159/000313425

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  4 in total

1.  Does pneumothorax occurrence correlate with a change in the weather?

Authors:  Toshiro Obuchi; Tatsu Miyoshi; Sou Miyahara; Wakako Hamanaka; Hiroyasu Nakashima; Jun Yanagisawa; Daisuke Hamatake; Takayuki Imakiire; Yasuteru Yoshinaga; Takeshi Shiraishi; Akinori Iwasaki
Journal:  Surg Today       Date:  2011-10       Impact factor: 2.549

Review 2.  Aeromedical Transport of Critically Ill Patients: A Literature Review.

Authors:  Alan Araiza; Melanie Duran; Salim Surani; Joseph Varon
Journal:  Cureus       Date:  2021-05-07

3.  Are pulmonologists well aware of planning safe air travel for patients with COPD? The SAFCOP study.

Authors:  Begüm Ergan; Hüseyin Arıkan; Metin Akgün
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-08-22

4.  BTS Clinical Statement on air travel for passengers with respiratory disease.

Authors:  Robina Kate Coker; Alison Armstrong; Alistair Colin Church; Steve Holmes; Jonathan Naylor; Katharine Pike; Peter Saunders; Kristofer John Spurling; Pamela Vaughn
Journal:  Thorax       Date:  2022-02-28       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.